Opus Genetics, Inc.
IRD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001228627
In the last 90 days, Opus Genetics, Inc. insiders filed 0 open-market purchases and 5 sales; 103 institutions reported holding it in 13F filings for Q2 2026, worth $236.4M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Opus Genetics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- +2 vs. Q2 2024
- Shares held
- 2.53M
- −57.6K (−2.2%) vs. Q2 2024
- Total value
- $3.32M
- −$646.5K (−16.3%) vs. Q2 2024
- New holders
- 8
- 6 more added
- Sold out
- 6
- 10 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IRD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 103 | $236.4M |
| Q1 2026 | 79 | $203.8M |
| Q4 2025 | 59 | $55.9M |
| Q3 2025 | 48 | $31.9M |
| Q2 2025 | 43 | $16.5M |
| Q1 2025 | 46 | $14.7M |
| Q4 2024 | 43 | $4.38M |
| Q3 2024 | 38 | $3.32M |
| Q2 2024 | 37 | $4.13M |
| Q1 2024 | 49 | $6.78M |
| Q4 2023 | 50 | $11.2M |
| Q3 2023 | 50 | $12.6M |
| Q2 2023 | 49 | $16.0M |
| Q1 2023 | 41 | $13.0M |
| Q4 2022 | 35 | $10.9M |
| Q3 2022 | 37 | $5.69M |
| Q2 2022 | 38 | $4.62M |
| Q1 2022 | 41 | $6.69M |
| Q4 2021 | 40 | $8.07M |
| Q3 2021 | 30 | $8.62M |
| Q2 2021 | 36 | $5.61M |
| Q1 2021 | 27 | $5.27M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Opus Genetics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 992,200 | $1.30M | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 272,281 | $356.8K | 0.00% | +6,427+2.4% | Added |
| Bridgeway Capital Management, LLC | 165,751 | $217.1K | 0.00% | +2,010+1.2% | Added |
| Richmond Brothers, Inc. | 155,620 | $203.9K | 0.13% | −35,684−18.7% | Reduced |
| BlackRock, Inc. | 109,323 | $143.2K | 0.00% | +109,323 | New |
| Knoll Capital Management, LLC | 100,000 | $131.0K | 0.06% | 00.0% | Unchanged |
| Citadel Advisors LLC | 86,819 | $113.7K | 0.00% | +72,721+515.8% | Added |
| Renaissance Technologies LLC | 70,609 | $92.5K | 0.00% | +28,909+69.3% | Added |
| State Street Corp | 70,473 | $92.3K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 56,096 | $73.5K | 0.00% | −90.0% | Reduced |
| Susquehanna International Group, LLP | 49,755 | $65.2K | 0.00% | +3,178+6.8% | Added |
| Kestra Private Wealth Services, LLC | 42,341 | $55.5K | 0.00% | 00.0% | Unchanged |
| Empowered Funds, LLC | 41,315 | $54.1K | 0.00% | +2,010+5.1% | Added |
| Blair William & Co | 33,267 | $43.6K | 0.00% | 00.0% | Unchanged |
| Diametric Capital, LP | 33,251 | $43.6K | 0.02% | −4,784−12.6% | Reduced |
| Trust Co of Toledo NA | 30,963 | $40.6K | 0.01% | 00.0% | Unchanged |
| Comerica Bank | 30,000 | $39.3K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 27,892 | $36.5K | 0.00% | +27,892 | New |
| Northern Trust Corp | 27,267 | $35.7K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 23,728 | $31.0K | 0.00% | +23,728 | New |
| Captrust Financial Advisors | 18,000 | $23.6K | 0.00% | 00.0% | Unchanged |
| Bedel Financial Consulting, Inc. | 15,000 | $19.6K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 13,905 | $18.2K | 0.00% | −7,650−35.5% | Reduced |
| Stokes Family Office, LLC | 12,120 | $15.9K | 0.00% | 00.0% | Unchanged |
| Prelude Capital Management, LLC | 12,110 | $15.9K | 0.00% | −1,742−12.6% | Reduced |
| Raymond James & Associates | 11,758 | $15.4K | 0.00% | +11,758 | New |
| Commonwealth Equity Services, LLC | 11,739 | $15.0K | 0.00% | +11,739 | New |
| UBS Group AG | 5,687 | $7.45K | 0.00% | −10,016−63.8% | Reduced |
| Tower Research Capital LLC (TRC) | 3,377 | $4.42K | 0.00% | −215−6.0% | Reduced |
| Wells Fargo & Company | 2,789 | $3.65K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 2,014 | $2.64K | 0.00% | −9,986−83.2% | Reduced |
| Barclays PLC | 1,900 | $2.49K | 0.00% | +1,900 | New |
| CarsonAllaria Wealth Management, Ltd. | 1,000 | $1.31K | 0.00% | 00.0% | Unchanged |
| Eastern Bank | 1,000 | $1.31K | 0.00% | +1,000 | New |
| Bank of America Corp | 202 | $265 | 0.00% | −11−5.2% | Reduced |
| Harbour Investments, Inc. | 40 | $52 | 0.00% | 00.0% | Unchanged |
| FSA Wealth Management LLC | 5 | $7 | 0.00% | +5 | New |
| Royal Bank of Canada | 5 | $0 | 0.00% | −21,940−100.0% | Reduced |
| Proequities, Inc. | 0 | $0 | 0.00% | −727−100.0% | Sold out |
| Rice Hall James & Associates, LLC | 0 | $0 | 0.00% | −223,589−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −42,375−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,335−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −76−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −26−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |